StockData

Spectral AI vs Profound Medical

MDAI and PROF side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How MDAI and PROF compare

Profound Medical grew revenue faster over the last twelve months (65.3% versus −44.1% for Spectral AI).

Spectral AI keeps more of each dollar of sales as profit, with a net margin of −65.5% compared with −138% at Profound Medical.

Profound Medical scores higher on the StockData Score (5 against 0 for Spectral AI), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricMDAIPROF
Size and price
Market cap$41.8M–
Share price$1.30$7.42
Change, 1 year−18.8%14.7%
Change, 5 years−86.8%−39.1%
Beta (5Y)0.491.02
Employees65162
StockData Score
Total score05 (better)
Valuation score00
Growth score03 (better)
Performance score00
Health score02 (better)
Dividend score00
Valuation
P/S2.7×–
Growth
Revenue growth (TTM)−44.1%65.3% (better)
Revenue growth, 5Y average–17.1%
EPS growth, 5Y average–2.4%
Profitability
Gross margin42.9%73.9% (better)
Operating margin−77.2% (better)−145%
Net margin−65.5% (better)−138%
Return on equity–−87.0%
Return on invested capital–−213%
Financial health
Debt / equity–0.11
Interest coverage−9.7× (better)−105.8×
Current ratio0.904.54 (better)
Altman Z-score−5.12–
Piotroski F-score33
Dividends and buybacks
Shareholder yield0.00%–
Ownership
Held by institutions21.4%45.2%
Held by insiders20.5%1.6%
Short interest, % of float–4.4%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.